Merck & Co is building a new biomanufacturing facility in Dublin, Ireland. The facility will be constructed on an existing property owned by Merck & Co – the site of its former facility in Swords, County Dublin. With the facility, the company expects to create up to 350 new jobs.

 

This follows an announcement by Merck & Co in May 2017 that the company planned to create 330 new jobs and invest €280 million ($350 million) over the next few years at two of its Irish manufacturing sites.

 

The company’s facility in County Cork an integrated site for the development, testing and manufacturing of biologics, specializing in the fermentation, purification and sterile filling of biologics products. The site in Carlow is the company’s first stand-alone vaccine and biologics manufacturing facility outside the USA.